Abstract
Background: Dapagliflozin, a selective Sodium-glucose cotransporter-2 (SGLT2) inhibitor, has been shown to play a key role in the control and manageme......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
